In summary, “targeting early steps of glucose metabolism (e.g. GAPDH activity) will enable us to block intracellular energy production and other critical pathways linked to it (e.g. macromolecular biosynthesis), eventually causing cancer cell death”. The gene discussed is GAPDH; the disease is cancer.